After a run-up due to COVID-induced demand, Silicon Valley mega-caps were supposed to get their comeuppance this year. It hasn’t happened. Read More

Now that the major opioid lawsuit has been settled, we wouldn’t be surprised to see JNJ follow Merck's lead and break up into smaller pieces. Read More

The market rally continued through Q2 of 2021. Here's a breakdown of how each of the 11 S&P 500 sectors fared. Read More

The first quarter of 2021 saw a broad-based rally across all sectors. Here is how each sector performed. Read More

2020 was a wild but generally profitable year in the markets. Here's how each sector performed for the year. We also provide guidance for 2021. Read More

This fund should rebound strongly in 2021 once the United Kingdom breaks free from COVID-19 and its economy fully reopens. Read More

Industrial businesses and online retailers both hit all-time highs last week, suggesting one or the other is mispriced. Here's how to profit. Read More

We’re seeing signs that maybe a bipartisan approach to fixing America’s economic woes will soon occur. That’s excellent news for investors. Read More

Now may be an opportune time to buy a put option on this soaring airline ETF, after drugmakers announced encouraging COVID-19 vaccine results. Read More

Economic prospects are bright for 2021, but in the interim, the journey will be rough. Here are the challenges and opportunities ahead. Read More